IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on June 1, 2008
(Investigative Ophthalmology and Visual Science. )
© 2008 by The Association for Research in Vision and Ophthalmology, Inc.
DOI:  10.1167/iovs.07-1101

This Article
Right arrow Full Text (P<P[PDF])
Right arrow All Versions of this Article:
iovs.07-1101v1
49/6/2577    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tchedre, K. T
Right arrow Articles by Yorio, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tchedre, K. T
Right arrow Articles by Yorio, T.

Article

Sigma-1 receptors protect RGC-5 cells from apoptosis by regulating intracellular calcium, Bax levels, and caspase-3 activation

Kissaou T Tchedre 1 and Thomas Yorio 2*

1 Pharmacology & Neuroscience, UNT Health Science Center, Fort Worth, Texas, United States
2 Pharmacology & Neuroscience, University of N. Texas Health Science Center, Fort Worth, Texas, United States

* To whom correspondence should be addressed. E-mail: yoriot{at}hsc.unt.edu.


   Abstract

PURPOSE: Sigma-1 receptor ligands prevent neuronal death associated with glutamate excitotoxicity both in vitro and in vivo. However, the molecular mechanism of the neuroprotective effect remains to be elucidated. Presently, we determined that sigma-1 receptor agonists provide neuroprotection by decreasing glutamate-induced calcium mobilization and prevent apoptotic gene expression. METHODS: Cell death was measured using the calcein-AM/propidium iodide cell survival assay. Western blot analysis determined the expression levels of Bax and caveolin-1 in normal RGC-5 cells. Immunocytochemistry compared the subcellular expression of sigma-1 receptors and caveolin-1 in normal RGC-5 cells. Caspase-3 activation after glutamate treatment was determined using the carboxyfluorescein caspase-3 detection kit. Glutamate-induced intracellular calcium mobilization was measured using ratiometric calcium imaging. RESULTS: Sigma-1 receptor overexpressing RGC-5 (RGC-5-S1R) cells have lower glutamate-induced intracellular calcium mobilization compared to normal RGC-5 cells and the sigma-1 receptor ligand (+)-SKF10047 reduced the glutamate calcium response in normal and RGC-5-S1R cells. (+)-SKF10047 protected RGC-5 cells from glutamate-induced cell death and RGC-5-S1R cells showed a significant resistance to glutamate-induced apoptosis compared to the control RGC-5 cells. BD1047, a sigma-1 receptor antagonist, blocked the protective effect of (+)-SKF10047. Western blot showed that (+)-SKF10047 inhibited the increase of Bax and Caveolin-1 after glutamate treatments. Glutamate-mediated cell death involved activation of caspase-3, and sigma-1 receptor activation prevented an increase in caspase-3 expression. CONCLUSIONS: These results suggest that sigma-1 receptors regulate intracellular calcium levels and prevent activation of pro-apoptotic genes and promote retinal ganglion cell survival. Thus, sigma-1 ligands appear to be neuroprotective and a potential target for glaucoma therapeutics.

Key Words: ganglion cell, glaucoma pharmacology, apoptosis




This article has been cited by other articles:


Home page
IOVSHome page
K. T. Tchedre, R.-Q. Huang, A. Dibas, R. R. Krishnamoorthy, G. H. Dillon, and T. Yorio
Sigma-1 Receptor Regulation of Voltage-Gated Calcium Channels Involves a Direct Interaction
Invest. Ophthalmol. Vis. Sci., November 1, 2008; 49(11): 4993 - 5002.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2008 by the Association for Research in Vision and Ophthalmology